A randomized, double-blind trial of half versus standard dose of zidovudine plus zalcitabine in Thai HIV-1-infected patients (study HIV-NAT 001). HIV Netherlands Australia Thailand Research Collaboration

Autor: Kroon, E. D., Ungsedhapand, C., Ruxrungtham, K., Chuenyam, M., Ubolyam, S., Newell, M. E., van Leeuwen, R., Kunanusont, C., Buranapraditkul, S., Sirivichayakul, S., Lange, J. M., Cooper, D. A., Phanuphak, P.

Publikováno v: AIDS (London, England), 14(10), 1349-1356. Lippincott Williams and Wilkins

Triple combination antiretroviral therapy, recommended as standard of care, is unaffordable for much of the developing world. To establish whether half doses of zidovudine (AZT) and zalcitabine (ddC) are as effective as standard doses in a Thai popul

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=narcis______::145c1d02f3cc8b2603a69e6da0f4bacd
https://pure.amc.nl/en/publications/a-randomized-doubleblind-trial-of-half-versus-standard-dose-of-zidovudine-plus-zalcitabine-in-thai-hiv1infected-patients-study-hivnat-001-hiv-netherlands-australia-thailand-research-collaboration(2ba2873a-071a-4f1b-9fce-8bab0fe34aad).html

A randomized, double-blind trial of half versus standard dose of zidovudine plus zalcitabine in Thai HIV-1-infected patients (study HIV-NAT 001). HIV Netherlands Australia Thailand Research Collaboration.

Autor: Kroon ED; Thai Red Cross AIDS Research Centre, Department of Internal Medicine, Academic Medical Centre, University of Amsterdam, The Netherlands., Ungsedhapand C, Ruxrungtham K, Chuenyam M, Ubolyam S, Newell ME, van Leeuwen R, Kunanusont C, Buranapraditkul S, Sirivichayakul S, Lange JM, Cooper DA, Phanuphak P

Publikováno v: AIDS (London, England) [AIDS] 2000 Jul 07; Vol. 14 (10), pp. 1349-56.